[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619300":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":23,"responsibleParty":36,"collaborators":7,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":48,"maxAge":7,"enrollmentInfo":49,"targetDuration":52,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":62,"whyStopped":7,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Institute of Tropical Medicine, Belgium","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Laurens Liesenborghs, MD","Institute of Tropical Medicine Antwerp","PRINCIPAL_INVESTIGATOR",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Christophe Van Dijck, PhD","CONTACT","+32 3 345 58 65","cvandijck@itg.be",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":22},"Clinical Trials Unit Antwerp","+32 3 247 66 66","studies@itg.be",[24],{"facility":25,"status":7,"city":26,"state":7,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":7},"Institute of Tropical Medicine","Antwerp","2000","Belgium","BE",{"type":31,"coordinates":32},"Point",[33,34],4.40026,51.22047,{"lat":34,"lon":33},{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100619300","prospective-follow-up-after-mva-bn-booster-vaccination-100619300",false,"NCT07342829","Prospective Follow-up After MVA-BN Booster Vaccination","Prospective On-site Study for the Immunological Follow-up of Individuals Who Received Booster Vaccination With MVA-BN Against Mpox","POQS-Boosted","Inclusion Criteria:\n\n1. Is scheduled to receive a booster dose of MVA-BN\n2. ≥18 years\n3. Willingness to provide written informed consent\n4. Willingness to follow the study schedule\n\nExclusion Criteria:\n\n1\\. Past or current MPXV infection",true,"ALL","18 Years",{"count":50,"type":51},95,"ESTIMATED","2 Years","OBSERVATIONAL","POQS-Boosted is a prospective observational study during which individuals who received Booster vaccination against mpox with the MVA-BN vaccine will be invited to provide biological samples at multiple times over the course of two years.",[56],"Monkeypox (Mpox)",[58,59,60,61],"mpox","immunology","vaccination","booster","NOT_YET_RECRUITING","2026-01-15",{"date":65,"type":66},"2026-01-20","ACTUAL",{"date":63,"type":51},{"date":69,"type":51},"2028-06-30",{"name":5,"class":6},1]